Ozempic, Mounjaro become pricier

Type 2 diabetes drugs Ozempic and Mounjaro are among the 775 brand-name drugs with higher prices in 2024, The Wall Street Journal reported Jan. 18. 

Ozempic increased by 3.5% to nearly $970 for a month's supply, and Mounjaro grew 4.5% to nearly $1,070 a month, according to data from 46brooklyn Research. The research organization has also noted an odd trend in 2024: Drug price deductions are canceling out the increases. 

Novo Nordisk, the maker of Ozempic, told the outlet that market conditions and inflation affect list prices, and Mounjaro-maker Eli Lilly said its medication prices are based on value, efficacy and safety.

Both medications are in a popular class of drugs called GLP-1s, or glucagon-like peptide-1 receptor agonists. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars